Could these twins hold the key to preventing cancer from a rare genetic disorder?

There is hope for people born with Leron in the form of a drug called Increlex.

The drug, which was first developed 15 years ago, can cause an increase in height if given during the growth period.

But the drug can be difficult to obtain and has several limitations – it can only be given to children between the ages of two and 18, and in some cases it has serious side effects.

Because it is only produced by one pharmaceutical company, it can cost upwards of $800 (£600) per bottle. A child with Laron syndrome needs at least three bottles a month, at a cost of $2,400, explains Dr. Guevara.

One of those struggling to get hold of the drug is Mayra Loiza.

Her two-year-old daughter Camilla was supposed to start her treatment six months ago but still hasn’t taken her first dose.

Meira, who lives in Pinas, is worried about how this will affect Camila’s development.

“I want my daughter to have as normal a life as possible. I don’t want her to be discriminated against because of her size,” she said, adding that she was confident the drug would increase Camilla’s height.

Twins Maria Luisa and 40-year-old Maria del Cecen were among those who escaped from a window after taking the drug.

While they wonder how different their lives would have been had it been available to them when they were younger, they say they have learned to live with their short stature.

“Now we accept ourselves as we are, but the treatment saved us from many pains,” said Maria Luisa.

“I accept myself as I am, I accept myself, and I thank God for who I am.”